logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
Y

Yeşim Eralp

Istanbul University

25H指数
166论文数
2.1K被引数
收录论文 26
发表时间
logo
First-line ribociclib (RIB) plus endocrine therapy (ET) vs combination chemotherapy (combo CT) in aggressive HR+/HER2-advanced breast cancer (ABC): A subgroup analysis of patients (pts) with or without visceral crisis from the phase II RIGHT choice study
errANNALS OF ONCOLOGY
IF65.4
err2023-10-01
err1
PREAI
errAzim, H. A.; El Saghir, N. S.; Yap, Y. S.; Eralp, Y.; Im, S-A.; Sandhu, M. S.; Abdel-Razeq, H.; Gupta, S.; Artamonova, E.; Rihani, J.; Alfaro, T. Delgar; Wu, J.; Hu, H.; Gao, M.; Lu, Y-S.
err分享
err收藏
Quality of life (QOL) analysis from the phase II RIGHT choice study of first-line ribociclib (RIB) plus endocrine therapy (ET) vs combination chemotherapy (combo CT) in aggressive HR+/HER2-advanced breast cancer (ABC)
errANNALS OF ONCOLOGY
IF65.4
err2023-10-01
err0
errOAAI
errEralp, Y.; Abdel-Razeq, H.; Im, S-A.; Rihani, J.; Lu, Y-S.; Yap, Y. S.; Azim, H. A.; Prasongsook, N.; Zhukova, L.; Hu, H.; Alfaro, T. Delgar; Wu, J.; Gao, M.; El Saghir, N. S.
err分享
err收藏
Clinical Applications of Combined Immunotherapy Approaches in Gastrointestinal Cancer: A Case-Based Review联合免疫治疗方法在胃肠道肿瘤中的临床应用: 基于病例的综述
errVACCINES
IF3.4
err2023-09-29
err2
errOAAI
errEralp, Yesim; Ates, Utku
err分享
err收藏
Demographic and clinical features of patients with metastatic HER2 positive breast cancer: a retrospective multicenter registry study of the Turkish Oncology Group
errCANCER RESEARCH
IF16.6
err2023-03-01
err0
PREAI
errEralp, Yesim; Dogan, Izzet; Aksoy, Sercan; Cakar, Burcu; Basaran, Gul; Ercelep, Ozlem; Molinas Mandel, Nil; Korkmaz, Taner; Gokmen, Erhan; Aydiner, Adnan; Saip, Pinar
err分享
err收藏
Primary results from the randomized Phase II RIGHT Choice trial of premenopausal patients with aggressive HR+/HER2-advanced breast cancer treated with ribociclib plus endocrine therapy vs physician's choice combination chemotherapy
errCANCER RESEARCH
IF16.6
err2023-03-01
err27
PREAI
errLu, Yen-Shen; Mahidin, Eznal Izwadi Bin Mohd; Azim, Hamdy; Eralp, Yesim; Yap, Yoon-Sim; Im, Seock-Ah; Rihani, Julie; Bowles, James; Alfaro, Teresa Delgar; Wu, Jiwen; Gao, Melissa; Slimane, Khemaies; El Saghir, Nagi
err分享
err收藏
Phase Ia/Ib study of RS-0139, a novel tumor-targeted delivery of docetaxel, in patients with recurrent, locally advanced, or metastatic non-small cell lung cancer (NSCLC)
errANNALS OF ONCOLOGY
IF65.4
err2022-09-01
err0
errOAAI
errOrer, H. S.; Nomak, G.; Oksuzoglu, B.; Senturk, R.; Eralp, Y.; Yumuk, F.; Nomak, H.; Sanyal, R.
err分享
err收藏
Application of mRNA Technology in Cancer TherapeuticsmRNA技术在肿瘤治疗中的应用
errVACCINES
IF3.4
err2022-08-05
err7
errOAAI
errEralp, Yesim
err分享
err收藏
Factors predicting a lower likelihood of residual nodal disease in clinically-node positive patients undergoing sentinel node surgery after neoadjuvant chemotherapy for breast cancer
errCANCER RESEARCH
IF16.6
err2022-02-15
err0
PREAI
errCabioglu, Neslihan; Karanlik, Hasan; Igci, Abdullah; Muslumanoglu, Mahmut; Tukenmez, Mustafa; Emiroglu, Selman; Ozkurt, Enver; Onder, Semen; Saip, Pinar; Eralp, Yesim; Aydiner, Adnan; Yavuz, Ekrem; Ozmen, Vahit
err分享
err收藏
TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer
errBMC CANCER
IF3.4
err2021-04-06
err18
errOAAI
errCabioglu, Neslihan; Onder, Semen; Oner, Gizem; Karatay, Huseyin; Tukenmez, Mustafa; Muslumanoglu, Mahmut; Igci, Abdullah; Eralp, Yesim; Aydiner, Adnan; Saip, Pinar; Yavuz, Ekrem; Ozmen, Vahit
err分享
err收藏
Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey
errCANCER RESEARCH
IF16.6
err2020-02-15
err0
PREAI
errDemirci, Umut; Gokmen, Erhan; Eralp, Yesim; Gunduz, Seyda; Goksu, Sema Sezgin; Korkmaz, Taner; Kostek, Osman; Turhal, Serdar; Paydas, Semra; Topcu, Sevgi; Cakar, Burcu; Karabulut, Bulent; Tanriverdi, Ozgur; Karaca, Burcak; Deniz, Gulhan Ipek; Alan, Ozkan; Turkoz, Fatma Paksoy; Basaran, Gul
err分享
err收藏
Follow-up of chemotherapy induced changes in anti-Mullerian hormone, antral follicle number and ovary volume in premenopausal breast cancer patients
errANNALS OF ONCOLOGY
IF65.4
err2016-10-01
err0
errOAAI
errElbuken, F.; Ordu, C.; Sarsenov, D.; Ilgun, S.; Pilanci, K.; Erdogan, Z.; Agacayak, F.; Alco, G.; Ozturk, A.; Eralp, Y.; Baysal, B.; Ozmen, V.
err分享
err收藏
The effect of internal mammary lymph node biopsy on the therapeutic decision and survival of patients with breast cancer
errEJSO
IF2.9
err2015-10-01
err12
PREAI
errOzmen, V.; Ozcinar, B.; Bozdogan, A.; Eralp, Y.; Yavuz, E.; Dincer, M.
err分享
err收藏
Does adjuvant chemotherapy induced amenorrhea effect survival in operated premenopausal breast cancer patients?
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2015-09-01
err0
PREAI
errOrdu, C.; Alco, G.; Pilanci, K. N.; Ilgun, S.; Sarsenov, D.; Celebi, F.; Erdogan, Z. Iyigun; Agacayak, F.; Demir, G.; Eralp, Y.; Tecimer, C.; Ozmen, V.
err分享
err收藏
The predictive and prognostic role of tumoral miRNA expression levels in patients with breast cancer (BC) treated with neoadjuvant chemotherapy (NAC)
errCANCER RESEARCH
IF16.6
err2013-12-15
err0
PREAI
errEralp, Y.; Keskin, S.; Gezer, U.; Tukenmez, M.; Muslumanoglu, M.; Dalay, N.; Disci, R.; Yavuz, E.; Igci, A.
err分享
err收藏
Which cytologically proven node-positive breast cancer patients can avoid axillary lymph dissection after neaodjuvant chemotherapy?
errCANCER RESEARCH
IF16.6
err2013-12-15
err0
PREAI
errKaranlik, H.; Ilhan, B.; Fayda, M.; Yavuz, E.; Mudun, A.; Saip, P.; Eralp, Y.; Kurul, S.; Aydiner, A.
err分享
err收藏
Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: A multicentric Turkish Oncology Group (TOG) trial
errBREAST
IF7.9
err2013-10-01
err7
errOAAI
errSaip, P.; Eralp, Y.; Sen, F.; Karaca, H.; Ozkan, M.; Cetin, B.; Benekli, M.; Kucukoner, M.; Isikdogan, A.; Un, O.; Basaran, G.; Onur, H.
err分享
err收藏
Induction Chemotherapy With Triweekly Docetaxel and Cisplatin Followed by Concomitant Chemoradiotherapy With or Without Surgery in Stage III Non-Small-Cell Lung Cancer: A Phase II Study
errCLINICAL LUNG CANCER
IF3.3
err2011-09-01
err8
PREAI
errAydiner, Adnan; Sen, Fatma; Saglam, Esra Kaytan; Oral, Ethem Nezih; Eralp, Yesim; Tas, Faruk; Toker, Alper; Dilege, Sukru
err分享
err收藏
Identification of patients who may benefit from the prophylactic cranial radiotherapy among breast cancer patients with brain metastasis
errJOURNAL OF NEURO-ONCOLOGY
IF3.1
err2008-12-20
err13
PREAI
errSaip, Pinar; Cicin, Irfan; Eralp, Yesim; Karagol, Hakan; Kucucuk, Seden; Alas, Rusen Cosar; Yavuz, Ekrem; Dincer, Maktav; Saglam, Esra; Topuz, Erkan
err分享
err收藏
Factors affecting the prognosis of breast cancer patients with brain metastases
errBREAST
IF7.9
err2008-10-01
err10
errOAAI
errSaip, Pinar; Cicin, Irfan; Eralp, Yesim; Kucucuk, Seden; Tuzlali, Sitki; Karagol, Hakan; Aslay, Isik; Topuz, Erkan
err分享
err收藏
Effect of adjuvant chemotherapy on integrity of free serum DNA in patients with breast cancer辅助化疗对乳腺癌患者血清游离DNA完整性的影响
errCIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V
IF0
err2008-09-16
err32
PREAI
errDeligezer, Ugur; Eralp, Yesim; Akisik, Elif Z.; Akisik, Ebru E.; Saip, Pinar; Topuz, Erkan; Dalay, Nejat
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
G
Gabriel N. Hortobágyi
H 指数: 187 · 论文数: 1.9K
A
Aman U. Buzdar
H 指数: 115 · 论文数: 720
S
Seock‐Ah Im
H 指数: 98 · 论文数: 1.1K
R
Richard L. Theriault
H 指数: 88 · 论文数: 391
H
Hai Hu
H 指数: 84 · 论文数: 399
查看更多